Global Nutrition & Vitamin Partnering Deals & Agreements, 2014-2019; Listed by Company (A-Z), Industry Sector, Stage of Development, and Technology Type

World News: . []

Dublin, March 15, 2019 (GLOBE NEWSWIRE) -- The report has been added to offering. This report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies.

The report provides understanding and access to the partnering deals and agreements entered into by the world's leading healthcare companies.The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases do not.This data driven report contains multiple links to online copies of actual deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.The initial chapters of this report provide an orientation of partnering trends.Chapter 1 provides an overview of the trends in partnering since 2014, including a summary of deals by industry sector, stage of development, deal type, and technology type. Chapter 2 provides a review of the top 10 most active companies in the therapy area, including a comprehensive listing of the deals announced by each company.Chapter 3 provides a comprehensive directory of partnering deals signed and announced since 2014. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand.Chapter 4 provides a listing of partnering deals where a contract document is available alongside the deal record.Chapters 5 and 6 provide a summary of M&A deals since 2014 where the acquired company is active in the therapy area of interest.Chapters 7 and 8 provide a summary of financings since 2014 where the financed company is active in the therapy area of interest.In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of technologies and products in the therapy area.

Research and Markets also offers services providing focused, comprehensive and tailored research.


CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Vitamins and Dietary Supplements

More news and information about Research and Markets

Published By:

Globe Newswire: 09:25 GMT Friday 15th March 2019

Published: .

Search for other references to "global" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us